Ingelvac庐 DART 2007-December-4
MATERIAL SAFETY DATA SHEET
1 PRODUCT AND COMPANY IDENTIFICATION
Product Name: Ingelvac庐 DART
Product No.: Not applicable
MSDS ID#: 7060.U1
GHS Product Identifier: Not applicable
Synonyms:
Molecular Formula: Mixture, not applicable
Molecular Weight: Not applicable
CAS Number: Mixture, not applicable
Chemical Family: Vaccine
Manufacturer: Emergency Telephone:
Boehringer Ingelheim Vetmedica, Inc. Transportation Emergency: (800) 424-9300
2621 North Belt Hwy
St. Joseph, MO 64506-2002 Medical Emergency (24HR): (866) 638-2226
Intended Use: Recommended for the Non-emergency Telephone: (800) 821-7467
vaccination of healthy, susceptible breeding
stock as an aid in the reduction of atrophic
rhinitis caused by Bordetella bronchiseptica
and Pasteurella multocida Type D.
2 HAZARDS IDENTIFICATION
Emergency Overview
Physical State: Solution of inactivated bacterin supplied in high density plastic bottles.
Color: White, opaque
Odor: No data available
WARNING!
For use in swine only.
Not for human use.
Allergic reactions can occur.
1/9
Ingelvac庐 DART 2007-December-4
Precautionary Statements:
Accidental human injection can cause serious local reactions or anaphylactic reaction and
systemic effects.
Keep only in original container.
Keep at a temperature between 2 - 7掳 C.
Do not freeze.
Fire-fighting: Use foam, carbon dioxide, dry powder and water fog or material appropriate for
surrounding fire.
Avoid contact with eyes, skin and clothing.
Wash thoroughly with soap and water after handling.
Wear suitable gloves and eye/face protection.
Spills: Cover with absorbent or contain. Collect and incinerate.
In case of accident or if you feel unwell, seek medical advice immediately (show the label where
possible).
Have the product container or label with you when calling a poison control center or doctor, or
going for treatment.
If swallowed, seek medical advice immediately and show this container or label.
This material and its container must be disposed of in a safe way.
Keep out of reach of children.
Keep away from food, drink, and animal feedstuffs.
Description: Recommended for the vaccination of healthy, susceptible breeding stock as an aid
in the reduction of atrophic rhinitis caused by Bordetella bronchiseptica and Pasteurella
multocida Type D.
Shake well before using. Use entire contents when first opened. Using aseptic technique, inject a
single 2 mL dose intramuscularly 5 鈥? 7 weeks before farrowing and a second 2 mL dose 2 鈥? 3
weeks prior to farrowing. Revaccinate with a single 2 mL dose intramuscularly 2 鈥? 3 weeks
before each farrowing.
Acute effect: Rarely, severe allergic reactions may occur that require immediate veterinary care.
Antidote: Epinephrine.
Precautions/Contraindications: Do not vaccinate within 60 days before slaughter.
Overdosage: None known.
ADVERSE REACTIONS TO PRODUCT: Anaphylactoid reactions may occur but are rare.
Potential Health Effects
Inhalation: Not expected to be an inhalation hazard with prescribed use.
Eye Contact: Not expected to be a hazard to the eye with prescribed use. Exposure to liquid in
eye may cause mild transient eye irritation.
Skin Contact: Not expected to be a hazard to the skin. Can cause hypersensitive reactions. May
cause skin sensitization by contact.
Ingestion: Not expected to be an ingestion hazard with prescribed use. Ingestion may cause
nausea and systemic effects.
2/9
Ingelvac庐 DART 2007-December-4
Injection: Swelling at injection site may occur.
Chronic Health Effects: Possible hypersensitization (development of abnormal sensitivity).
Target Organ(s): Gastrointestinal system, respiratory system, skin
Potential Physical Effects: Can cause skin sensitization.
OSHA Regulatory Status: Nonhazardous
Environment: No data available
3 COMPOSITION / INFORMATION ON INGREDIENTS
Chemical Name EC No. CAS- No. Concentration Classification Notes
Inactivated bacterin 鈥? ---- ---- proprietary ---- ---
Bordetella
bronchiseptica
Inactivated bacterin 鈥? ---- ---- proprietary ---- ---
Pasteurella multocida
鈮? 0.74 g/L
*formaldehyde 2000018 50-00-0 23/24/25/ 34 40 43 ---
The full texts for all R-Phrases are displayed in Section 16, if applicable.
* Used to inactivate virus and subsequently removed from solution. Concentration represents maximum remaining
amount which is below USDA allowable limits.
4 FIRST AID MEASURES
General: Animals or persons developing anaphylactic (life-threatening) reactions, such as
difficulty in breathing or unconsciousness, must receive immediate medical attention.
Inhalation: Move to fresh air. Treat symptomatically. Get medical attention if symptoms persist.
Eye Contact: Any material that contacts the eye should be washed out immediately with water. If
easy to do, remove contact lenses. Get medical attention if symptoms persist.
Skin Contact: In case of contact, immediately flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. If skin irritation or rash occurs, seek
medical advice. Wash contaminated clothing before reuse.
Ingestion: Call a physician or poison control center immediately. Only induce vomiting at the
instruction of medical personnel. Never give anything by mouth to an unconscious person.
Injection: In case of accidental injection, wash the site thoroughly. Contact a physician
immediately.
Note to Physician: For use in swine only.
Antidote: Epinephrine is indicated for anaphylactoid reactions.
3/9
Ingelvac庐 DART 2007-December-4
5 FIRE-FIGHTING MEASURES
Extinguishing Media: Extinguish with foam, carbon dioxide, dry powder and water fog or
material appropriate for surrounding fire.
Unsuitable Extinguishing Media: None known
Special Fire Fighting Procedures: Wear self-contained breathing apparatus and protective
clothing.
Unusual Fire & Explosion Hazards: None known
Hazardous Combustion Products: Carbon monoxide, carbon dioxide
Flammability Class: 0
6 ACCIDENTAL RELEASE MEASURES
Personal Precautions: Wear appropriate personal protective equipment (See Section 8).
Spill Cleanup Methods: Small liquid spill: Use a non-combustible material like vermiculite,
earth or sand to soak up the product and place into container for later disposal. Incinerate. For
large liquid spill: Absorb or cover with dry earth, sand or other non-combustible material and
transfer to containers. Incinerate.
Environmental Precautions: Prevent runoff from entering drains, sewers or streams. Dike for
later disposal.
7 HANDLING AND STORAGE
Handling: Avoid contact with eyes, skin and clothing. Avoid accidental injection. Wash
thoroughly with soap and water after handling. Use only with adequate ventilation.
Storage: Store at 2掳-7掳 C (35掳-45掳 F). Do not freeze. Shake well before using.
8 EXPOSURE CONTROLS / PERSONAL PROTECTION
For Industrial Exposures:
Exposure Limits:
Formaldehyde ACGIH 8-HR TWA 0.3 ppm Irritation, cancer
Formaldehyde OSHA Action 0.5 ppm Cancer-suspect
Level agent
0.5 mg/m3
Formaldehyde Austria TWA Justifiably
suspected of
carcinogenic
potential. Skin
absorption.
Sensitizer
4/9
Ingelvac庐 DART 2007-December-4
0.92 mg/m3
Formaldehyde Alberta 8-HR TWA Irritation
Formaldehyde British Columbia 8-HR TWA 0.3 ppm Capable of
causing
respiratory,
dermal or
conjunctival
sensitization.
1.5 mg/m3
Formaldehyde Ontario 8-HR TWA ----
3 mg/m3
Formaldehyde Quebec Ceiling ----
Exposure
Value
0.38 mg/m3
Formaldehyde Belgium 15-minute Irritant
STEL
0.4 mg/m3
Formaldehyde Denmark Ceiling ----
0.37 mg/m3
Formaldehyde Finland 8-HR Limit ----
Formaldehyde France Short Term 1 ppm ----
Limit
0.37 mg/m3
Formaldehyde Germany 8-HR TWA
0.25 mg/m3
Formaldehyde Greece 8-HR TWA ----
0.4 mg/ m3
Formaldehyde Iceland 8-HR TWA Allergenic
substance
2.5 mg/m3
Formaldehyde Ireland 8-HR TWA ----
Formaldehyde Italy Ceiling 0.3 ppm ---
limit
1.5 mg/m3
Formaldehyde Netherlands MAC TWA ----
0.6 mg/m3
Formaldehyde Norway TLV Allergenic
substance
Formaldehyde Portugal Ceiling 0.3 ppm Sensitizer,
Exposure suspected
limit human
carcinogen
0.37 mg/m3
Formaldehyde Spain 15-minute Sensitizer
STEL
0.6 mg/m3
Formaldehyde Sweden Level Limit ----
Value
(NGV)
0.37 mg/m3
Formaldehyde Switzerland TWA Sensitizing
substance
2.5 mg/m3
Formaldehyde United Kingdom TWA ----
Engineering Controls: Not generally required when handling vials or containers. Good
ventilation (typically 10 air changes per hour) should be used. Ventilation rates should be
matched to conditions. If applicable, use process enclosures, local exhaust ventilation, or other
engineering controls to maintain airborne levels below recommended exposure limits. If exposure
limits have not been established, maintain airborne levels to an acceptable level.
Respiratory Protection: Not generally required when handling vials or containers. If
engineering controls do not maintain airborne concentrations below recommended exposure
limits (where applicable) or to an acceptable level (in countries where exposure limits have not
been established), an approved respirator must be worn. In the United States of America, if
5/9
Ingelvac庐 DART 2007-December-4
respirators are used, a program should be instituted to assure compliance with OSHA standard 63
FR 1152, January 8, 1998. Respirator type: NIOSH approved organic vapor respirator.
Europe: Wear appropriate personal protective equipment according to the Council
Directive 89/686/EEC (4) and the appropriate CEN standards.
PERSONAL PROTECTIVE EQUIPMENT: Not generally required when handling containers.
If containers are compromised or exposure to the active ingredient or mixture is likely wear:
Eye Protection: Wear safety glasses with side shields (or goggles).
Hand Protection: Wear suitable gloves.
Skin Protection: Wear protective clothing appropriate for the risk of exposure.
Hygiene Measures: Eye bath, washing facilities, shower
9 PHYSICAL AND CHEMICAL PROPERTIES
Color: White, opaque
Odor: No data available
Odor Threshold: No data available
Physical State: Solution of inactivated bacterin supplied in high density plastic bottles.
pH: 6.3 鈥? 6.7
Melting Point: No data available
Freezing Point: No data available
Boiling Point: No data available
Flash Point: No data available
Flammability Limit 鈥? Upper (%): No data available
Flammability Limit 鈥? Lower (%): No data available
Evaporation rate: No data available
Vapor Pressure: No data available
Vapor Density (Air=1): No data available
Specific Gravity: No data available
Solubility: No data available
Partition Coefficient (n-Octanol/water): No data available
Autoignition Temperature: Not applicable
Decomposition Temperature: No data available
10 STABILITY AND REACTIVITY
Stability: Stable
Conditions to Avoid: Temperatures below 2掳 C (35掳 F)
Incompatible Materials: Strong oxidizing agents
Hazardous Decomposition Products: None known
Possibility of Hazardous Reactions: Will not occur.
6/9
Ingelvac庐 DART 2007-December-4
11 TOXICOLOGICAL INFORMATION
Ingelvac庐 DART is considered nontoxic.
Listed Carcinogens: None
12 ECOLOGICAL INFORMATION
Ecotoxicity: No data available
Persistence and degradability: No data available
Mobility in soil: No data available
Other adverse effects: No data available
Germany WGK: Not applicable
13 DISPOSAL CONSIDERATIONS
General Information: Dispose of in accordance with local, state, federal, national or
international regulations.
Disposal Methods: Incinerate containers and unused contents. Do not empty into drains; dispose
of this material and its container in a safe way. Do not contaminate water, food, or feed by
disposal.
RCRA Information: Not applicable
14 TRANSPORT INFORMATION
DOT: Not regulated
TDG: Not regulated
ADR/RID: Not regulated
IATA: Not regulated
IMDG: Not regulated
15 REGULATORY INFORMATION
Canadian Controlled Products Regulations: This product has been classified according to the
hazard criteria of the Canadian Controlled Products Regulations, Section 33, and the MSDS
contains all required information.
WHMIS Classification: Noncontrolled, exempt
Inventory Status
This material is not listed on the following inventories: TSCA, DSL, AICS, EINECS, IECSC, ENCS,
PICCS, KECI, and NZIoC. Therefore, it can only be used for TSCA exempt purposes such as R&D or
7/9
Ingelvac庐 DART 2007-December-4
veterinary use. In the United States, this product is regulated by the USDA Animal and Plant Health
Inspection Service (APHIS).
Canada CEPA Schedule 1 - Formaldehyde
US Regulations
CERCLA Hazardous Substance List (40 CFR 302.4): None
SARA Title III
Section 302Extremely Hazardous Substance (40 CFR 355, Appendix A): None
Section 311/312 (40 CFR 370): None
Section 313 Toxic Release Inventory (40 CFR 372): None
Clean Air Act (CAA) Section 112(r) Accidental Release Prevention (40 CFR 68.130): None
Clean Water Act Section 311 Hazardous Substances (40 CFR 117.3): None
State Regulations
California Safe Drinking Water and Toxic Enforcement Act of 1986 (Proposition 65):
Formaldehyde (gas)
Massachusetts Right-To-Know List: Formaldehyde
Minnesota Hazardous Substances List: None
New Jersey Right-To-Know List: None
Pennsylvania Right-To-Know List: Formaldehyde
Rhode Island Right-To-Know List: Formaldehyde
European Regulations
Austria MAK List (Annex I): Formaldehyde
Denmark (Annex 3.6, April 2005): Formaldehyde
Germany (Dangerous Substances Ordinance 2004, Annex III): None
Norway (List of Dangerous Substance): None
Sweden (Sensitizers- Annex 3): Formaldehyde
Switzerland (Toxins List 1): Formaldehyde
16 OTHER INFORMATION
Hazard Ratings
Health Hazard Fire Hazard Reactivity Hazard
1 0 0
HMIS
Health Hazard Fire Hazard Reactivity Hazard Special Hazard
1 0 0 N/A
NFPA
*- Chronic health effect; 0 鈥? Minimal; 1 鈥? Slight; 2 鈥? Moderate; 3 鈥? Serious; 4 鈥? Severe
R and S Phrase Definitions
R23/24/25 鈥? Harmful by inhalation, in contact with skin and if swallowed.
R40 鈥? Limited evidence of a carcinogenic effect.
8/9
Ingelvac庐 DART 2007-December-4
R43 鈥? May cause sensitization by skin contact.
S(1/2) 鈥? Keep locked up and out of reach of children.
S24 鈥? Avoid contact with skin.
S26 鈥? In case of contact with eyes, rinse immediately with plenty of water and seek medical
advice.
S36/37/39 鈥? Wear suitable protective clothing, gloves and eye/face protection.
S45 鈥? In case of accident or if you feel unwell, seek medical advice immediately (show the label
where possible).
S51 鈥? Use only in well-ventilated areas.
ABBREVIATIONS:
BIV - Boehringer Ingelheim Vetmedica, Inc.
N/A - Not applicable
N/E - Not established
pph 鈥? parts per hour
References:
1. Ariel WebInsight Regulatory Database. Regulatory Summary for North America,
Western Europe, and Global Inventories Database.
2. GHS Manual
3. Ingelvac庐 DART Label
Prepared by: Boehringer Ingelheim Vetmedica, Inc.
Issue Date: 12/04/07
Revision Information: New
Disclaimer: The information provided herein is offered by Boehringer Ingelheim Vetmedica, Inc.
(鈥淏IV鈥?) in good faith as accurate as of the date hereof, but without guarantee. This information
includes information which has been generated by other parties and provided to BIV, and which
BIV has not independently verified. The information provided herein relates only to the specific
product designated, and may not be valid where such product is used in combination with any
other materials or in any process. The information provided herein is offered solely for your
consideration, investigation and verification, and Boehringer Ingelheim Vetmedica, Inc. (鈥淏IV鈥?)
expressly disclaims all liability for reliance thereon. BIV EXPRESSLY DISCLAIMS ALL
WARRANTIES OF EVERY KIND AND NATURE (INCLUDING WARRANTIES OF
MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE) WITH RESPECT
TO THE USE OR SUITABILITY OF THE PRODUCT. In addition, since the conditions of use
and suitability of the product for particular uses are beyond BIV鈥檚 control, ALL RISKS OF USE
OF THE PRODUCT ARE THEREFORE ASSUMED BY THE USER, AND BIV EXPRESSLY
DISCLAIMS ANY AND ALL LIABILITY AS TO ANY RESULTS OBTAINED OR
ARISING FROM ANY USE OF THE PRODUCT. Use or transmission of the information
contained herein in any other format than the format as presented is strictly prohibited. Nothing
herein shall be construed as permission or recommendation for the use of the product in a manner
that might infringe an existing patent. BIV neither represents nor warrants that the format, content
or product formulas contained in this document comply with the laws of any other country except
the United States of America.
漏 Copyright 2001 Boehringer Ingelheim Vetmedica, Inc. All rights reserved.
9/9
|